Expertise

We advised the shareholders of earthware, an award-winning creative digital agency on its strategic acquisition by Prime Global. The new partnership will increase capabilities being offered to pharmaceutical companies undergoing digital transformation.

We advised the shareholders of The Happy Puzzle Company on the cross-border sale of the business to Smart N.V. The partnership will enable the company to accelerate its international growth plans.

We are retained by the Green New Deal Fund, a low carbon investment fund to identify investment opportunities in the North of Tyne region. The Green New Deal Fund is focused on low carbon and renewable technologies.

We provide Investor Relations and Communications services to Tekmar Group PLC. Tekmar Group PLC are listed on the London Stock Exchange PLC.

We are retained by Medical Incubator Japan (“MIJ”), a Japanese investment fund to help identify investment opportunities in the UK and Europe and provide research support. MIJ is focused on the areas of Pharmaceutical, Medical Devices and Digital Health. 

We are retained by RA International to provide Investor Relations and Communications services. RA International are listed on the London Stock Exchange PLC.

We advised the shareholders of Advanté on the sale of the business to Modulaire Group following a successful dual track process to find a buyer. This was the conclusion of a multi-year relationship working with the shareholders and management and resulted in a very successful outcome for all parties.

We advised the Pioneer Healthcare team on the sale of the business to Totally PLC. This successful process resulted in the right partnership to drive expansion and strategic growth.

We provided corporate finance and strategic advice to Mudano for several years culminating in a process to explore options to support the next phase of growth for Mudano. This process resulted in an acquisition by Accenture from their Applied Intelligence division.

We advised the management and founder shareholders of a management  consultancy and technology business on its sale to a leading UK private  equity firm. The business had grown rapidly in recent years and the  transaction provided an exit for initial founder investor shareholders, a partial exit for management, and the opportunity to realign the  shareholder base for the next phase of growth.

We helped specialist build to rent provider Rise Homes Limited raise equity funding from private equity firm Gresham House. When combined with senior debt, this enabled Rise to develop two initial schemes in the North West of England as part of its goal to create a leading a provider of high-quality PRS accommodation aimed at the mass market.

We helped management negotiate an acquisition of Epistem from Genedrive PLC, establish a growth plan and then raised £2m of funding from Foresight Group to fund the consideration and provide development capital.

We acted for the shareholders (NorthEdge and Management) on the IPO of Ramsdens Holdings PLC, raising £15.6m. A year later we acted again for NorthEdge on a subsequent placing of their residual shareholding, raising a further £15.6m.

We helped establish a UK company and raised £1.25m to fund the acquisition of IP and provide growth capital to develop and commercialise antimicrobial technology SILVERbac.

We acted for the founders of Orbit Debt Collections Limited at a time of significant growth to help them explore strategic options for the business. This resulted in a sale of the business to the Cabot Financial Group which provided a structured exit for shareholders plus support and investment for further growth.

We acted for the founder of Neudrive in acquiring IP from the Centre for Process Innovation and raising funds.

We advised on the IPO of Concepta following the previous fundraise.

We acted for NorthEdge when they provided acquisition and development funding for Direct Healthcare Services. We provided commercial and strategic advice.

We acted for the majority shareholder of Casdon plc to raise debt funding to acquire the other minority shareholdings and undertake a Takeover Code compliant Recommended Offer.

We acted as the Rule 3 Adviser on the £12m Takeover Code compliant Recommended Offer of Vindon Healthcare plc by Source Bioscience plc.

We were co-founders of Collagen Solutions helping the CEO acquire a clean room facility based in Glasgow out of Administration. We raised funds from High Net Worth individuals and 12 months later arranged an IPO and advised on 2 pivotal acquisitions, one in the US and one in New Zealand.

We acted for the founders of Proveca Limited to help create their business plan and then raise £2.6m from Albion Ventures. We continue to be a retained advisor to Proveca.

We acted for Horizon Discovery in assisting in a pre-IPO bridging  fundraise.

We acted for the founders of Harvey Walsh Limited on the sale of the business to Open Health (part of Chime Communications plc).